Covetrus, Inc. (NASDAQ:CVET)’s traded shares stood at 562,179 during the last session, with the company’s beta value hitting 0. At the close of trading, the stock’s price was $35.95, to imply a decline of -2.55% or -$0.94 in intraday trading. The CVET share’s 52-week high remains $40.78, putting it -13.44% down since that peak but still an impressive +88.73% since price per share fell to its 52-week low of $4.05. The company has a valuation of $4.88 Billion, with an average of 597.81 Million shares in intraday trading volume over the past 10 days and average of 905.03 Million shares over the past 3 months.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Analysts have given a consensus recommendation of Overweight for Covetrus, Inc. (CVET), translating to a mean rating of 2.4. Of 8 analyst(s) looking at the stock, 1 analyst(s) give CVET a Sell rating. 1 of those analysts rate the stock as Overweight while 2 advise Hold as 4 recommend it as a Buy. None analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at $0.16.

Covetrus, Inc. (NASDAQ:CVET) trade information

After registering a -2.55% downside in the last session, Covetrus, Inc. (CVET) has traded red over the past five days. The stock hit a weekly high of $40.71 this Friday, Feb 12, jumping 11.69% in its intraday price action. The 5-day price performance for the stock is -9.88%, and -1.64% over 30 days. Despite these dips, the year-to-date price performance is 25.09%. Short interest in Covetrus, Inc. (NASDAQ:CVET) saw shorts transact 5.98 Million shares and set a 0.01 days time to cover.

Analysts on Wall Street suggest a consensus price target of $31.2, implying a decline of -13.21% to the stock’s current value. The extremes give us $18 and $48 for target low and target high price respectively. As such, CVET has been trading 33.52% off suggested target high and -49.93% from its likely low.

Covetrus, Inc. (CVET) estimates and forecasts

Revenue forecast for the current quarter as set by 6 analysts is $1.05 Billion. Meanwhile, for the quarter ending March 01, 2021, a total of 6 analyst(s) estimate revenue growth to $1.08 Billion. Earnings reports from the last fiscal year show that sales brought in $1.01 Billion and $1.06 Billion respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 4.6% before jumping 1.2% in the following quarter.

An assessment of the company’s 5-year growth patterns shows that annual earnings fell an estimated 0% for the past 5-year period. While 2021 is set for a 6.5% return in earnings, projections for the next 5 years are at 0% annually.

Covetrus, Inc. (NASDAQ:CVET)’s Major holders

Covetrus, Inc. insiders hold 1.07% of total outstanding shares, with institutional holders owning 103.75% of the shares at 104.87% float percentage. In total, 367 institutions holds shares in the company, led by Clayton, Dubilier & Rice, LLC. As of Dec 30, 2020, the company held over 33.68 Million shares (or 26.41% of shares), all amounting to roughly $967.87 Million.

A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.


The next major institution holding the largest number of shares is Blackrock Inc. with 15.92 Million shares, or about 12.49% of shares outstanding. As of the market price on Dec 30, 2020, these shares were worth $457.57 Million.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free


Please enter your comment!
Please enter your name here